We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$5.96M
Cap. Flow %
-2.51%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.63%
2 Materials 25.45%
3 Miscellaneous 11.79%
4 Financials 10.86%
5 Real Estate 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CYPH icon
51
Cypherpunk Technologies Inc
CYPH
$277M
$792K 0.33%
90,000
+49,105
+120% +$597K
2022 Q1
2 quarters
ARDX icon
52
Ardelyx
ARDX
$798M
$774K 0.33%
+650,000
New +$618K
2022 Q3
0 quarters
MDLZ icon
53
Mondelez International
MDLZ
$81.6B
$768K 0.32%
14,000
– –
2021 Q4
3 quarters
SNY icon
54
Sanofi
SNY
$97.3B
$760K 0.32%
+20,000
New +$891K
2022 Q3
0 quarters
CCOI icon
55
Cogent Communications
CCOI
$413M
$730K 0.31%
14,000
– –
2022 Q1
2 quarters
MCRB icon
56
Seres Therapeutics
MCRB
$24.7M
$706K 0.3%
+5,500
New +$563K
2022 Q3
0 quarters
WHWK icon
57
Whitehawk Therapeutics
WHWK
$165M
$693K 0.29%
49,039
+35,000
+249% +$460K
2022 Q2
1 quarter
FNB icon
58
FNB Corp
FNB
$6.13B
$690K 0.29%
59,485
– –
2021 Q4
3 quarters
KMB icon
59
Kimberly-Clark
KMB
$35.1B
$675K 0.28%
6,000
– –
2021 Q4
3 quarters
FAZEW
60
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$671K 0.28%
58,321
– –
2021 Q4
3 quarters
PCYO icon
61
Pure Cycle
PCYO
$266M
$668K 0.28%
80,000
– –
2022 Q1
2 quarters
CTVA icon
62
Corteva
CTVA
$8.59B
$661K 0.28%
11,563
– –
2021 Q4
3 quarters
LGV
63
DELISTED
Longview Acquisition Corp. II
LGV
$627K 0.26%
63,900
– –
2021 Q4
3 quarters
MTB icon
64
M&T Bank
MTB
$31.1B
$617K 0.26%
3,500
– –
2022 Q1
2 quarters
AUPH icon
65
Aurinia Pharmaceuticals
AUPH
$2.2B
$607K 0.26%
80,694
– –
2022 Q1
2 quarters
DD icon
66
DuPont de Nemours
DD
$17.6B
$561K 0.24%
8,872
– –
2021 Q4
3 quarters
KO icon
67
Coca-Cola
KO
$404B
$538K 0.23%
9,600
– –
2021 Q4
3 quarters
PSTX icon
68
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$534K 0.22%
+151,286
New +$500K
2022 Q3
0 quarters
HVBC
69
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$519K 0.22%
25,000
– –
2022 Q1
2 quarters
MGTX icon
70
MeiraGTx Holdings
MGTX
$891M
$507K 0.21%
60,295
+8,545
+17% +$75.3K
2022 Q1
2 quarters
DOW icon
71
Dow Inc
DOW
$21.6B
$489K 0.21%
11,136
– –
2021 Q4
3 quarters
CDTX icon
72
DELISTED
Cidara Therapeutics
CDTX
$431K 0.18%
34,301
+2,538
+8% +$35K
2021 Q4
3 quarters
MSFT icon
73
Microsoft
MSFT
$3.93T
$373K 0.16%
1,600
– –
2021 Q4
3 quarters
ADMA icon
74
ADMA Biologics
ADMA
$2.39B
$370K 0.16%
152,301
– –
2021 Q4
3 quarters
IBER
75
DELISTED
Ibere Pharmaceuticals
IBER
$357K 0.15%
36,000
– –
2021 Q4
3 quarters
1 2
3
4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Materials and Miscellaneous.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.